# Novogene

测序与生物信息 CRO，服务约 90 个国家逾 7,300 家客户，拥有 547 项软件著作权。

Source: https://cn.bioecon.ru/companies/novogene/
Updated: 2026-06-24

- 国家: China
- 代码: SSE: 688315

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | $7500万 B轮融资（人民币5.15亿）及人民币2亿 A轮融资 (2016-11-30) | https://www.biospace.com/novogene-completes-75-million-series-b-funding-round, https://www.novogene.com/eu-en/about/major-milestones/ |
| 认证 | CAP、ISO 13485、ISO 17025及CLIA认证 (2025-12-31) | https://stockmc.xueqiu.com/202604/688315_20260415_BVXL.pdf, https://www.biospace.com/novogene-completes-75-million-series-b-funding-round, https://www.novogene.com/eu-en/about/major-milestones/ |
| 监管批准 | NovoFocus NSCLC CDx检测及Digital PCR NG生物芯片扫描仪获CFDA批准；高通量测序肿瘤基因检测试剂盒于2018年获NMPA批准 (2024-01-01) | https://stockn.xueqiu.com/SH688315/20250414877208.pdf, https://www.novogene.com/eu-en/about/major-milestones/ |
| 生产基地 | 实验室或试验基地位于中国北京、天津、南京、广州、上海；美国（萨克拉门托、Beaverton）、英国（剑桥）、德国、新加坡及日本 (2025-12-31) | http://static.cninfo.com.cn/finalpage/2026-04-15/1225103514.PDF, https://sapac.illumina.com/company/news-center/feature-articles/chinas-novogene-global-force.html, https://stockmc.xueqiu.com/202604/688315_20260415_BVXL.pdf, https://www.biospace.com/novogene-completes-75-million-series-b-funding-round |
| 员工人数 | 1,000余名员工（技术与管理团队） (2025-12-31) | http://static.cninfo.com.cn/finalpage/2026-04-15/1225103514.PDF, https://stockmc.xueqiu.com/202604/688315_20260415_BVXL.pdf |
| 营收 | 人民币22.096亿（2025年年营收） (2025-12-31) | http://static.cninfo.com.cn/finalpage/2026-04-15/1225103514.PDF, https://stockmc.xueqiu.com/202604/688315_20260415_BVXL.pdf |

独立来源: biospace.com, sapac.illumina.com, static.cninfo.com.cn, stockmc.xueqiu.com, stockn.xueqiu.com

## 技术

- [代谢组学服务](https://cn.bioecon.ru/technology/metabolomics-service/)
- [单细胞组学](https://cn.bioecon.ru/technology/single-cell-omics/)
- [生物信息与多组学](https://cn.bioecon.ru/technology/bioinformatics-multi-omics/)
